Skip to content
OpenCapital
Get started

Pacira BioSciences, Inc. PCRX Change in fair value of contingent consideration

Change in fair value of contingent consideration at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$0+100%

Segments

By segment

See full
Reportable Segment-$2.28M+14.9%

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$942.78M-14.5%
Enterprise value$1.21B+2.6%
P/E183.5×—
P/S1.3×-0.3×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%—
Net margin0.7%—
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%—
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s change in fair value of contingent consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s change in fair value of contingent consideration?
Pacira BioSciences, Inc. (PCRX) reported change in fair value of contingent consideration of -$2.28M in Q1 2026.
How has Pacira BioSciences, Inc.'s change in fair value of contingent consideration changed year-over-year?
Pacira BioSciences, Inc.'s change in fair value of contingent consideration increased by 14.9% year-over-year, from -$2.68M to -$2.28M.
What does change in fair value of contingent consideration mean?
Reflects the non-cash change in the fair value of liabilities related to acquisition-based earn-outs or contingent payments. Fluctuations in this value indicate adjustments to the estimated future payouts owed to sellers of acquired businesses based on performance milestones.